- Home
- SOWG vs CODX Comparison
SOWG vs CODX Comparison
Compare SOWG & CODX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOWG
- CODX
- Stock Information
- Founded
- SOWG 2010
- CODX 2013
- Country
- SOWG United States
- CODX United States
- Employees
- SOWG N/A
- CODX N/A
- Industry
- SOWG Packaged Foods
- CODX Medical/Dental Instruments
- Sector
- SOWG Consumer Staples
- CODX Health Care
- Exchange
- SOWG Nasdaq
- CODX Nasdaq
- Market Cap
- SOWG 22.6M
- CODX 22.0M
- IPO Year
- SOWG N/A
- CODX 2017
- Fundamental
- Price
- SOWG $2.43
- CODX $0.48
- Analyst Decision
- SOWG Strong Buy
- CODX Hold
- Analyst Count
- SOWG 2
- CODX 1
- Target Price
- SOWG $23.00
- CODX $1.50
- AVG Volume (30 Days)
- SOWG 33.8K
- CODX 199.5K
- Earning Date
- SOWG 03-21-2025
- CODX 05-08-2025
- Dividend Yield
- SOWG N/A
- CODX N/A
- EPS Growth
- SOWG N/A
- CODX N/A
- EPS
- SOWG 0.21
- CODX N/A
- Revenue
- SOWG $40,130,971.00
- CODX $7,321,012.00
- Revenue This Year
- SOWG $122.17
- CODX N/A
- Revenue Next Year
- SOWG N/A
- CODX N/A
- P/E Ratio
- SOWG $11.63
- CODX N/A
- Revenue Growth
- SOWG 508.45
- CODX 57.16
- 52 Week Low
- SOWG $1.98
- CODX $0.46
- 52 Week High
- SOWG $24.83
- CODX $2.23
- Technical
- Relative Strength Index (RSI)
- SOWG 46.21
- CODX 31.25
- Support Level
- SOWG $2.20
- CODX $0.46
- Resistance Level
- SOWG $2.36
- CODX $0.68
- Average True Range (ATR)
- SOWG 0.19
- CODX 0.07
- MACD
- SOWG 0.01
- CODX 0.00
- Stochastic Oscillator
- SOWG 47.13
- CODX 12.00
About SOWG Sow Good Inc. Common Stock
Sow Good Inc is engaged in manufacturing and marketing freeze-dried fruits, vegetables, snacks, smoothies, and soups. The company also sells gluten-free granola products under the Sow Good brand. The company is developing a freeze-dried candy market and snack manufacturing to provide consumers with flavorful freeze-dried treats.
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.